Literature DB >> 15046269

Major malformations in infants exposed to antiepileptic drugs in utero, with emphasis on carbamazepine and valproic acid: a nation-wide, population-based register study.

K Wide1, B Winbladh, B Källén.   

Abstract

AIM: Antiepileptic drugs (AEDs) are known teratogens. Some specificity between different AEDs has been noted in the literature. The aim was to compare the teratogenic effect of valproic acid (VPA) and carbamazepine (CBZ) in monotherapy.
METHODS: Infants exposed to AEDs (n = 1398) in early pregnancy were identified from the Swedish Medical Birth Registry. The number of infants with congenital malformations and exposed to AED was compared with the expected number estimated from all infants born (n = 582656).
RESULTS: 90% (1256) of the AED exposed children were exposed to AEDs in monotherapy, 56% were exposed to CBZ and 21% to VPA. The odds ratio (OR) for having a malformation in the AED exposed group was 1.86 [95% confidence interval (95% CI) 1.42-2.44]. Exposure to VPA in monotherapy compared with CBZ in monotherapy gave OR = 2.51 (95% CI 1.43-4.68) for a neonatal diagnosis of malformations. However, there is no information available on the number of therapeutic abortions, or the different types of epilepsy or drug dosage in the two treatment groups.
CONCLUSION: There was a small increase in the risk of having a major malformation after exposure to AEDs in monotherapy. Exposure to VPA seems to carry a higher risk than exposure to CBZ.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15046269     DOI: 10.1080/08035250310021118

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  59 in total

1.  NICE guidance on newer drugs for epilepsy in adults.

Authors:  Emilio Perucca
Journal:  BMJ       Date:  2004-05-29

2.  Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register.

Authors:  J Morrow; A Russell; E Guthrie; L Parsons; I Robertson; R Waddell; B Irwin; R C McGivern; P J Morrison; J Craig
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-09-12       Impact factor: 10.154

3.  Using current evidence in selecting antiepileptic drugs for use during pregnancy.

Authors:  Page B Pennell
Journal:  Epilepsy Curr       Date:  2005 Mar-Apr       Impact factor: 7.500

Review 4.  Major malformations with valproic acid.

Authors:  Gideon Koren; Alejandro A Nava-Ocampo; Myla E Moretti; Reuven Sussman; Irena Nulman
Journal:  Can Fam Physician       Date:  2006-04       Impact factor: 3.275

Review 5.  In utero exposure to antiepileptic drugs: teratogenicity and neonatal morbidity.

Authors:  Tarannum Musvee Lateef; Karin B Nelson
Journal:  Curr Neurol Neurosci Rep       Date:  2007-03       Impact factor: 5.081

Review 6.  Neuropsychological and behavioral effects of antiepilepsy drugs.

Authors:  David W Loring; Susan Marino; Kimford J Meador
Journal:  Neuropsychol Rev       Date:  2007-10-18       Impact factor: 7.444

Review 7.  Epilepsy in pregnancy.

Authors:  Torbjörn Tomson; Vilho Hiilesmaa
Journal:  BMJ       Date:  2007-10-13

8.  Alteration of bioelectrically-controlled processes in the embryo: a teratogenic mechanism for anticonvulsants.

Authors:  Sonia Hernández-Díaz; Michael Levin
Journal:  Reprod Toxicol       Date:  2014-05-06       Impact factor: 3.143

9.  Teratogenicity of lamotrigine.

Authors:  Sarit Shor; Gideon Koren; Irena Nulman
Journal:  Can Fam Physician       Date:  2007-06       Impact factor: 3.275

Review 10.  Pregnancy outcomes in women with epilepsy: a systematic review and meta-analysis of published pregnancy registries and cohorts.

Authors:  Kimford Meador; Matthew W Reynolds; Sheila Crean; Kyle Fahrbach; Corey Probst
Journal:  Epilepsy Res       Date:  2008-06-18       Impact factor: 3.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.